Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : | NSE Symbol : | ISIN : | Industry : |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
15-Oct-2024	23-Oct-2024	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve PFA Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Wednesday 23rd October 2024. 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September 2024. The meeting commenced at 03:45 P.M. and concluded at 04:15.P.M. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated on: 23/10/2024)
30-Jul-2024	13-Aug-2024	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Pursuant to Regu lation 29 ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of t he Company will be held on Tuesday 13th August 2024 inter alia to consider following business. Please take the above intimation in your records. Thanking You. PFA (As per BSE Announcement Dated on 13/08/2024)
22-May-2024	30-May-2024	Accounts	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 30th May 2024 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. Audited Financial Results for the year ended on 31st March, 2024 (As Per BSE Announcement Dated on 30.05.2024)
18-Jan-2024	13-Feb-2024	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday February 13 2024 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Tuesday 13th February 2024. 1.) Considered and approved Un-audited financial results for the quarter ended as on 31st December 2023. The meeting commenced at 04:00 P.M. and concluded at 04:30.P.M. Kindly take the same on your record and oblige. Thanking You (As per BSE Announcement Dated on 13/02/2024)
26-Oct-2023	08-Nov-2023	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday November 8 2023 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2023 and also transact other business activities. Please take the above intimation in your records. Thanking you. Requirements) Regulations, 2015 In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2023 and The meeting commenced at 03.30 P.M. and concluded at 04.00 P.M. Kindly take the same on your record and oblige. Thanking You. PFA (As Per BSE Announcement Dated on 08/11/2023)
05-Aug-2023	14-Aug-2023	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 14th August 2023 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 14th August 2023 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2023. The board meeting started on 03.30 P.M and concluded on 04.00. P.M Please take the above intimation in your records. Thanking You. PFA (As Per BSE Announcement Dated on 14.08.2023)
23-May-2023	30-May-2023	Accounts	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 30th May 2023 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2023. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. This is to inform you that Outcome of the Board Meeting of the Company held on Tuesday 30th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 05:00 P.M. Request you to kindly take on record the same. Thanking You. This is to inform you that Outcome of the Board Meeting of the Company held on Tuesday 30th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 05:00 P.M. Request you to kindly take on record the same. Thanking You. (As Per BSE Announcement Dated on 30.05.2023)
15-Feb-2023	21-Feb-2023	Change in Directors	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 21st February 2023 inter alia to consider following businesses. 1. To consider the Appointment of Mr. Harshad Rathod as Director of the Company. 2. To accept the resignation of Mr. Prakashbhai Pravinbhai Dataniya from directorship of the company Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2022 and board meeting concluded on 13.15 P.M (As per BSE Announcement Dated on 14/02/2023) Pursuant to Second proviso to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e Tuesday 21st February, 2023, at the Registered Office of the Company and board meeting concluded at 04.30 P.M. 1. Considered & approved the Appointment of Mr. Harshad Rathod as Director of the Company. 2. Considered and accepted the resignation of Mr. Prakashbhai Pravinbhai Dataniya from directorship of the company Please take the above intimation in your records. Thanking You. (As Per BSE Announcement dated on 21.02.2023)
07-Feb-2023	14-Feb-2023	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 14th February 2023 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2022 also transact other business activities. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2022 and board meeting concluded on 13.15 P.M. Kindly take the same on your record and oblige. (As per BSE Announcement Dated on 14/02/2023)
02-Nov-2022	09-Nov-2022	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday November 09 2022 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2022 and also transact other business activities. Please take the above intimation in your records. Thanking you. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2022. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated on 09/11/2022)
07-Jul-2022	25-Jul-2022	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 25th July 2022 inter alia to consider following business. 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You 1. Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2022. 2. Consider and accepted the Resignation of Mr.Varun Aghara from the Post of Chief Financial Officer of the Company w.e.f 25.07.2022. 3. Mr. Kishan Nityanand Naidu is appointed as Chief Financial Officer of the Company w.e.f 25.07.2022. 4. Ms.Manisha Patel has resigned from the post of directorship of the Company w.e.f 25.07.2022. 5. Mr.Nimesh Parmar is appointed as Director of the Company w.e.f 25.07.2022. 6. Ms. Amruta Solanki is appointed as Director of the Company w.e.f 25.07.2022. Kindly take the same on your record and oblige. Thanking You. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday July 25, 2022 at the Registered Office of the Company and transacted the following business. Note: Due to typo error and erratum find herewith revised Un-Audited Financial Result quarter ending 30th June, 2022 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday July 25, 2022 at the Registered Office of the Company and transacted the following business. Note: Due to typo error and erratum find herewith revised Un-Audited Financial Result quarter ending 30th June, 2022 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015. Thanking You, (As per BSE Announcement Dated on 25/07/2022)
05-May-2022	23-May-2022	Accounts	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2022 inter alia to consider and approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2022. 2. Any other matter with the permission of the board which the Board may think fit. This is to inform you that Outcome of the Board Meeting of the Company held on Monday 23rd May 2022 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2022. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2022. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2022 with unmodified opinion. Request you to kindly take on record the same. Thanking You. (As Per BSE Announcement dated on 23.05.2022)
29-Apr-2022	29-Apr-2022	Bonus Issue	Apropos the captioned subject please be informed that the Board of Directors have in the allotment meeting held on April 29, 2022 alloted 19,93,12,000 bonus equity shares to the shareholders entitled for these shares subsequently increasing the paid up and issued capital of the Company from Rs. 19,93,12,000/-(divided into 19,93,12,000 equity shares of the face value of Rs.1/-each) to Rs. 39,86,24,000/-(divided into 39,86,24,000 equity shares of the face value of Rs.1/-each). We further wish to inform that the said 19,93,12,000 bonus shares will be credited to the account of respective shareholders on or before May 6,2022. This is for your information and records pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you.
03-Feb-2022	07-Mar-2022	Bonus Issue	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2022 inter alia to consider and approve the declaration of issue of bonus shares to the equity shareholders of the company. Kindly take the above intimation into your records. Thanking you. This is to inform that the Board of Directors at its meeting held on Monday, 07th March, 2022 have approved and recommended the issuance of fully paid-up Bonus Shares in the ratio of 1:1 (i.e. 1 (one) fully paid up equity share for every 1 (one) fully paid up equity share held, subject to the shareholders'' approval through Postal Ballot. Please take the above intimation in your records. Thanking You. (As Per BSE Announcement Dated on 07.03.2022)
25-Jan-2022	01-Feb-2022	Quarterly Results	Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday February 1 2022 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2021 also transact other business activities. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith un-audited financial result for quarter ended 31st December 2021. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement dated on 01.02.2022)

1 2